ClinicalTrials.Veeva

Menu

Validation of Noninvasive Hemoglobin, Comparison of PVI to Standard Methods, and Validation of Clinical Efficacy of ORI

Masimo logo

Masimo

Status

Completed

Conditions

Surgery

Treatments

Device: Masimo Pulse CO-Oximeter

Study type

Interventional

Funder types

Industry

Identifiers

NCT02841397
DORO0001

Details and patient eligibility

About

The study goal is to establish the correlation of hemoglobin values determined by the noninvasive pulse oximetry-determined hemoglobin (SpHb) system with hemoglobin as measured by other validated devices. The study will also evaluation oxygen reserve index (ORI) to correlate with partial pressure of oxygen (PaO2), and to evaluate pleth variability index (PVI) with stroke volume variation (SVV) or pulse pressure variation (PPV) values.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Admitted into the ICU
  • Aged 18 years or older
  • Mechanically ventilated
  • Arterial line placed
  • Vigileo/Flotrac System being used for guidance of fluid management

Exclusion criteria

  • Pregnancy
  • Prisoner status
  • Extreme hemodynamic instability
  • Multiple vasopressors in use with questionable peripheral blood flow
  • Lack of appropriate sites for sensor placement
  • Patient or patient's legal representative refusal

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Test group
Experimental group
Description:
All subjects will be enrolled into the test group and will receive Masimo Pulse CO-Oximeter for measurement of various physiological parameters.
Treatment:
Device: Masimo Pulse CO-Oximeter

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems